Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89,827 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Latent Tuberculosis Infection and Associated Factors in Patients with Systemic Lupus Erythematosus: a Multicenter, Cross-Sectional Study.
Zhang L, Ma Y, Jiang N, Zou X, Zhang Y, Zhang F, Zeng X, Zhao Y, Liu S, Zuo X, Wu H, Wu L, Li H, Zhang Z, Chen S, Zhu P, Zhang M, Qi W, Liu Y, Liu H, Shi X, Liu X. Zhang L, et al. Among authors: liu y, liu h, liu x, liu s. Microbiol Spectr. 2023 Jun 15;11(3):e0084823. doi: 10.1128/spectrum.00848-23. Epub 2023 May 9. Microbiol Spectr. 2023. PMID: 37158726 Free PMC article.
Classification criteria of early rheumatoid arthritis and validation of its performance in a multi-centre cohort.
Zhao J, Su Y, Li R, Ye H, Zou Q, Fang Y, Liu H, Li X, Guo J, Bi L, Gu F, Sun L, Mei Y, Zhang Z, Chen L, Zhu P, Li G, Zhang Z, Leng X, Zhao Y, Jiang L, Zou H, Zhao Y, Liu Y, Li L, Wang H, Liu X, Li Z. Zhao J, et al. Among authors: liu y, liu h, liu x. Clin Exp Rheumatol. 2014 Sep-Oct;32(5):667-73. Epub 2014 Sep 5. Clin Exp Rheumatol. 2014. PMID: 25190289
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial.
Li R, Zhao JX, Su Y, He J, Chen LN, Gu F, Zhao C, Deng XR, Zhou W, Hao YJ, Xue Y, Liu HX, Zhao Y, Zou QH, Liu XY, Zhu P, Sun LY, Zhang ZL, Zou HJ, Li XF, Liu Y, Fang YF, Keystone E, McInnes IB, Li ZG. Li R, et al. Medicine (Baltimore). 2016 Jul;95(28):e3968. doi: 10.1097/MD.0000000000003968. Medicine (Baltimore). 2016. PMID: 27428186 Free PMC article. Clinical Trial.
Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study.
Bi L, Li Y, He L, Xu H, Jiang Z, Wang Y, Li X, Wei W, Gu J, Wang G, Zhang Z, Zhou B, Liu Y, Wu Z, Liu H, He D, Lv Z, Li Z, Zuo X, Dong L, Wu H, Zhang H, Chen H, Bao C, Zhang Z, Zhang M, Song H, Zheng Y, Jiang L, Liu X, Boehnlein M, Dunkel J, Shao J, Harris K, Li Z. Bi L, et al. Among authors: liu y, liu h, liu x. Clin Exp Rheumatol. 2019 Mar-Apr;37(2):227-234. Epub 2018 Aug 29. Clin Exp Rheumatol. 2019. PMID: 30183595 Free article. Clinical Trial.
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter, Randomized, Double-Blind, Parallel, Phase III Clinical Trial.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: liu y, liu h, liu x. BioDrugs. 2020 Jun;34(3):381-393. doi: 10.1007/s40259-020-00408-z. BioDrugs. 2020. PMID: 32078145 Free PMC article. Clinical Trial.
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: liu y, liu h, liu x. Front Pharmacol. 2020 Dec 7;11:606497. doi: 10.3389/fphar.2020.606497. eCollection 2020. Front Pharmacol. 2020. PMID: 33364967 Free PMC article.
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study.
Su J, Li M, He L, Zhao D, Wan W, Liu Y, Xu J, Xu J, Liu H, Jiang L, Wu H, Zuo X, Huang C, Liu X, Li F, Zhang Z, Liu X, Dong L, Li T, Chen H, Li J, He D, Lu X, Huang A, Tao Y, Wang Y, Zhang Z, Wei W, Li X, Zeng X. Su J, et al. Among authors: liu y, liu h, liu x. Clin Rheumatol. 2022 Mar;41(3):731-739. doi: 10.1007/s10067-021-05943-w. Epub 2021 Oct 28. Clin Rheumatol. 2022. PMID: 34709497 Free PMC article. Clinical Trial.
Efficacy and Safety of CMAB008 Compared with Innovator Infliximab in Patients with Moderate-to-Severe Rheumatoid Arthritis Receiving Concomitant Methotrexate: A Randomized, Double-blind, Multi-center, Phase III Non-inferiority Study.
Ye H, Liu S, Xu J, Chai K, He D, Fang Y, Xie Q, Liu H, Liu Y, Hua B, Hu J, Zhang Z, Zhou M, Zhao D, Li Y, Jiang Z, Wang M, Li J, Zhang Z, Li X, Li Y, Sun E, Bi L, Wei W, Tie N, He L, Huang X, Zhang Y, Huang Q, Wang X, Liu X, Li J, Su Y. Ye H, et al. Among authors: liu y, liu h, liu x, liu s. Rheumatol Ther. 2023 Jun;10(3):757-773. doi: 10.1007/s40744-023-00544-2. Epub 2023 Mar 25. Rheumatol Ther. 2023. PMID: 36964872 Free PMC article.
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.
Wu D, Li J, Xu D, Merrill JT, van Vollenhoven RF, Liu Y, Hu J, Li Y, Li F, Huang C, Wang G, Li X, Zhao J, Zhao D, Huang C, Liu H, Wei W, Shi G, Lu F, Zuo X, Bi L, Li Z, Wang X, Zhang M, Tie N, Li J, Mo H, Fang J, Bao C, Zhang F. Wu D, et al. Among authors: liu y, liu h. Ann Rheum Dis. 2024 Mar 12;83(4):475-487. doi: 10.1136/ard-2023-224854. Ann Rheum Dis. 2024. PMID: 38129117 Free PMC article. Clinical Trial.
89,827 results
You have reached the last available page of results. Please see the User Guide for more information.